Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AA34893 in Bipolar I or II Depression
NCT00622245Phase 2Terminated
- Sponsor
- Lundbeck
- Start
- Jan 2008
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 2 trial of LU AA34893 in bipolar disorder (BD), sponsored by Lundbeck. Started Jan 2008; status: terminated.
02
Drugs
LU AA34893
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00622245.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00622245.